From: Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
Variablesa | B | Std. Error | t | P Value | 95.0% Confidence Interval for B | ||
---|---|---|---|---|---|---|---|
Lower Bound | Upper Bound | ||||||
(Constant) | 73.438 | 15.261 | 4.812 | .000 | 43.129 | 103.747 | |
Arbidol group | 2.596 | .837 | 3.102 | .003 | .934 | 4.258 | |
Without IHDb | −3.842 | 1.482 | −2.593 | .011 | −6.786 | −.899 | |
Without DMb | .122 | 1.005 | .121 | .904 | −1.874 | 2.118 | |
WBC | .113 | .093 | 1.214 | .228 | −.072 | .298 | |
Oxygen saturation | −.238 | .061 | −3.900 | .000 | −.359 | −.117 | |
Lymphocytosis | −.089 | .048 | −1.865 | .065 | −.183 | .006 | |
Na level | −.300 | .112 | −2.670 | .009 | −.523 | −.077 |